HealthEquity, Inc.
HQY
$84.61
-$0.60-0.70%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.58% | 9.47% | 12.20% | 15.45% | 19.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.58% | 9.47% | 12.20% | 15.45% | 19.21% |
| Cost of Revenue | -8.51% | -5.25% | 4.47% | 10.51% | 12.36% |
| Gross Profit | 16.05% | 17.48% | 16.30% | 18.11% | 23.16% |
| SG&A Expenses | 4.15% | -3.51% | -1.81% | 1.40% | 6.83% |
| Depreciation & Amortization | -5.18% | -3.51% | -0.08% | 6.21% | 19.12% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.95% | -1.10% | 4.27% | 8.19% | 11.37% |
| Operating Income | 42.61% | 61.42% | 49.93% | 52.70% | 67.59% |
| Income Before Tax | 94.40% | 139.10% | 112.88% | 41.73% | 56.46% |
| Income Tax Expenses | 113.47% | 221.92% | 186.40% | 57.45% | 79.09% |
| Earnings from Continuing Operations | 89.40% | 122.54% | 98.37% | 38.01% | 51.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 89.40% | 122.54% | 98.37% | 38.01% | 51.44% |
| EBIT | 42.61% | 61.42% | 49.93% | 52.70% | 67.59% |
| EBITDA | 23.57% | 31.98% | 25.96% | 27.65% | 36.03% |
| EPS Basic | 92.31% | 124.23% | 98.79% | 37.75% | 50.09% |
| Normalized Basic EPS | 59.59% | 81.94% | 61.92% | 60.29% | 78.25% |
| EPS Diluted | 94.68% | 125.37% | 100.30% | 37.74% | 49.23% |
| Normalized Diluted EPS | 60.91% | 82.79% | 62.22% | 60.40% | 77.95% |
| Average Basic Shares Outstanding | -1.54% | -0.84% | -0.26% | 0.52% | 1.16% |
| Average Diluted Shares Outstanding | -2.34% | -1.35% | -0.37% | 0.54% | 1.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |